C43.7
Malignant melanoma of lower limb, including hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant melanoma of the lower limb, including the hip, is a serious type of skin cancer that develops from pigment-producing cells called melanocytes. While melanoma can occur anywhere on the body, its emergence on the lower limbs and hips is particularly notable. Recognizing the signs and understanding the underlying causes can aid in early detection and prompt treatment. This article provides an informative overview of this condition, its potential causes, symptoms, diagnostic methods, and treatment options.
Causes & Symptoms
Clinical Causes: Excessive exposure to ultraviolet (UV) rays from sunlight or tanning beds. Having a fair or light skin complexion that is more susceptible to sun damage. History of sunburns, especially blistering burns during childhood or adolescence. Genetic predisposition, including a family history of melanoma or other skin cancers. Presence of atypical moles or numerous moles on the body. Weakened immune system, which may impair the body's ability to detect and fight abnormal cell growth. Exposure to certain chemicals or carcinogens, though this is less common.
Key Symptoms: A new or existing mole that changes in size, shape, color, or texture. Asymmetry in the shape of a pigmented lesion. Borders that are irregular, blurred, or notched. Uneven or multiple colors within the same mole, such as shades of brown, black, pink, or red. Diameter larger than 6 mm, though smaller moles can also be problematic. Itching, tenderness, or pain in a mole or pigmented area. Surface changes like bleeding, crusting, or oozing. The appearance of a dark streak or band on a nail that may be indicative of subungual melanoma.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive skin examination by a healthcare professional, focusing on the detection of atypical moles or pigmented lesions. If suspicion arises, a biopsy is performed where a small sample of the lesion is removed and examined under a microscope for cancerous cells. Additional assessments may include:
Treatment Protocols: Surgical excision to remove the tumor and some surrounding tissue to ensure complete removal. Sentinel lymph node biopsy to evaluate if the cancer has spread to nearby lymph nodes. Immunotherapy to boost the body's immune response against melanoma cells. Targeted therapy drugs that attack specific genetic mutations within the cancer cells. Radiation therapy in cases where surgery isn't feasible or to treat metastasis. Chemotherapy, though less commonly used today, may be considered for advanced stages.
Clinical Advice & FAQs
Billing Guidance
Is C43.7 a billable ICD-10 code?
Yes, C43.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C43.7?
Clinical documentation must specify the nature of Malignant melanoma of lower limb, including hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
